semaglutide and colonoscopy prep 2-Day MiraLAX® Your patient took semaglutide this

Diabetologia (2004) 47(Suppl 1):A47

These were presented as dermatology-meeting abstracts, were industry-associated, used surrogate cosmetic endpoints (skin density by ultrasound, wrinkle profilometry, investigator grading), and are summarised second-hand in review articles far more often than they are read in full

Lilly's Zepbound demonstrated significantly greater weight reduction compared to Novo Nordisk's Wegovy in SURMOUNT-5 head-to-head trial

Key trials included SUSTAIN 6, a cardiovascular outcomes trial demonstrating significant reduction in major adverse cardiovascular events (MACE) compared to placebo (HR 0.74